Greiner Bio-One North America, Inc. Warning Letter Details

Summary

Based on limited metadata, this FDA Warning Letter issued to Greiner Bio-One North America, Inc. on April 16, 2020, concerns medical devices manufactured by the company. Without access to the full letter text or subject line, the specific nature of the violations cannot be determined from the available information. The warning falls under FDA's medical device regulatory authority, though the specific issuing office is not identified in the metadata provided.